S Malhotra1, G E Tesar, K Franco
1Department of Psychiatry and Psychology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk P57, Cleveland, OH 44022, USA.
Depression is a significant risk factor for cardiovascular disease, increasing the likelihood of cardiac events and mortality. The Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) is a key study investigating antidepressant treatment for cardiovascular risk.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: